A key Food and Drug Administration advisory committee will review and vote on the Covid-19 vaccine with a single Johnson & Johnson injection on Friday, which could pave the way for an emergency use authorization in the coming days. If authorized, J & J’s shot would be the third available in the United States and distributed through a relatively simple supply chain: the single-dose regimen eliminates the need to track return visits, and the drug can be stored at lower temperatures. extreme than the vaccines produced by Pfizer and Moderna. The streamlined supply and simplified logistics would probably mean an immediate increase in national vaccination rates when the vaccine enters the market as early as next week.
The United States has at least 73,300 new cases of Covid-19 and at least 2,160 virus-related deaths each day, based on a seven-day average calculated by CNBC using data from Johns Hopkins University.
The following data were compiled by Johns Hopkins University:
- Global cases: over 113.08 million
- Deaths worldwide: at least 2.5 million
- Cases in the USA: over 28.41 million
- US deaths: at least 508,314